Radosław Zagożdżon

Author

Radosław Zagożdżon

Also Known As

>Radosław Zagożdżon, J. Kawiak, R Zagozdzon, R Zagożdżon, R. Zagozdzon, R. Zagożdżon, Radoslaw Zagozdzon, Radoslaw Zagożdżon, Radosław Zagozdzon, Radosław Zagożdżon

154

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Medical University of Warsaw Institute of Biochemistry and Biophysics, Polish Academy of Sciences Beth Israel Deaconess Medical Center Postgraduate School of Molecular Medicine Harvard University

About

Radosław Zagożdżon is an author at Medical University of Warsaw specializing in medicine, tumor biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	530
2	Natural Sciences	2	2	78
3	Biochemistry	2	2	78
4	Health Sciences	1	1	16
5	Allergy	1	1	38

Radosław Zagożdżon

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk‐Jarzynka, Cancer Immunology Research	2018	106
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice Wojciech Feleszko, Radosław Zagożdżon, Jakub Gołąb, European Journal of Cancer Tumor BiologyAntitumour EffectsMedicinePharmacologyImmune Checkpoint Inhibitor	1998	85
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer Patrick C. O’Leary, Marta Terrile, Małgorzata Bajor, Breast Cancer Research	2014	77
Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells Emilia Białopiotrowicz, Monika Noyszewska‐Kania, Neli Kachamakova‐Trojanowska, Cancers	2020	63
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents Małgorzata Bajor, Agata O. Zych, Agnieszka Graczyk‐Jarzynka, British Journal of Cancer	2018	62
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells Małgorzata Bajor, Agnieszka Graczyk‐Jarzynka, Katsiaryna Marhelava, Journal for ImmunoTherapy of Cancer	2022	55
Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF Grzegorz M. Wilczyński, Radosław Zagożdżon, Anna Dąbrowska, British Journal of Cancer	2000	54
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer Patrick C O ́Leary, Sarah Penny, Róisín Dolan, BMC Cancer	2013	54
Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy Antoni Domagała, Joanna Stachura, Magdalena Gabrysiak, BMC Cancer	2018	52
Statins impair glucose uptake in human cells Dominika Nowis, Agata Malenda, Karolina Furs, BMJ Open Diabetes Research & Care	2014	48

Page 1